Skip to main content
Erschienen in: Applied Health Economics and Health Policy 5/2018

01.10.2018 | Original Research Article

Development of Conversion Functions Mapping the FACT-B Total Score to the EQ-5D-5L Utility Value by Three Linking Methods and Comparison with the Ordinary Least Square Method

verfasst von: Chun Fan Lee, Raymond Ng, Nan Luo, Yin Bun Cheung

Erschienen in: Applied Health Economics and Health Policy | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Health-related quality-of-life (HRQoL) measures are commonly mapped to a value that represents a utility for economic evaluation via regression models, which may lead to shrinkage of the variance.

Objectives

This study aimed to develop and compare conversion functions that map the Functional Assessment of Cancer Therapy—Breast (FACT-B) total score to the EuroQoL 5-Dimensions, 5-Levels (EQ-5D-5L) utility value via four methods.

Methods

We used the HRQoL scores of 238 Singapore patients with breast cancer to develop the conversion function for the equipercentile, linear equating, mean rank and ordinary least squares (OLS) methods. We compared the distributions of the observed values and the four sets of mapped values and performed regression analyses to assess whether the association with risk factors was preserved by utility values derived from mapping.

Results

At baseline, the observed EQ-5D-5L utility value had a mean ± standard deviation (SD) of 0.820 ± 0.152, and 24.8% of the respondents attained a value of 1. The OLS method (mean 0.820; SD 0.112; proportion 0%) better agreed with the observed data than the equipercentile (mean 0.831; SD 0.152; proportion 23.5%), linear equating (mean 0.814; SD 0.145; proportion 11.8%) and mean rank method (mean 0.821; SD 0.147; proportion 23.9%). The significance of association was preserved for all parameters involved in the regression analyses by the equipercentile and linear equating methods, but the mean rank and OLS methods were inconsistent with the observed data for one and two parameters, respectively.

Conclusion

The problem of shrinkage in the variance occurred in the OLS method, but it provided an unbiased estimate for the mean and better agreement. Among the other three linking methods, the mean rank method better described the distribution, whereas the equipercentile and linear equating methods better assessed the association with risk factors.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000;17:13–35.CrossRefPubMed Coons SJ, Rao S, Keininger DL, Hays RD. A comparative review of generic quality-of-life instruments. Pharmacoeconomics. 2000;17:13–35.CrossRefPubMed
2.
Zurück zum Zitat Puhan MA, Gaspoz JM, Bridevaux PO, Schindler C, Ackermann-Liebrich U, Rochat T, et al. Comparing a disease-specific and a generic health-related quality of life instrument in subjects with asthma from the general population. Health Qual Life Outcomes. 2008;6:15.CrossRefPubMedPubMedCentral Puhan MA, Gaspoz JM, Bridevaux PO, Schindler C, Ackermann-Liebrich U, Rochat T, et al. Comparing a disease-specific and a generic health-related quality of life instrument in subjects with asthma from the general population. Health Qual Life Outcomes. 2008;6:15.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Longworth L, Rowen D. Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value Health. 2013;16:202–10.CrossRefPubMed Longworth L, Rowen D. Mapping to obtain EQ-5D utility values for use in NICE health technology assessments. Value Health. 2013;16:202–10.CrossRefPubMed
6.
Zurück zum Zitat Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11:215–25.CrossRefPubMed Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11:215–25.CrossRefPubMed
7.
Zurück zum Zitat Dakin H. Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health Qual Life Outcomes. 2013;11:151.CrossRefPubMedPubMedCentral Dakin H. Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database. Health Qual Life Outcomes. 2013;11:151.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Fayers PM, Hays RD. Should linking replace regression when mapping from profile-based measures to preference-based measures? Value Health. 2014;17:261–5.CrossRefPubMedPubMedCentral Fayers PM, Hays RD. Should linking replace regression when mapping from profile-based measures to preference-based measures? Value Health. 2014;17:261–5.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Wee HL, Yeo KK, Chong KJ, Khoo EYH, Cheung YB. Mean rank, equipercentile and regression mapping of World Health Organization Quality of Life Brief (WHOQOL-BREF) to EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) utilities. Med Decis Making. 2018;38:319–33.CrossRefPubMed Wee HL, Yeo KK, Chong KJ, Khoo EYH, Cheung YB. Mean rank, equipercentile and regression mapping of World Health Organization Quality of Life Brief (WHOQOL-BREF) to EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) utilities. Med Decis Making. 2018;38:319–33.CrossRefPubMed
10.
Zurück zum Zitat Lee CF, Luo N, Ng R, Wong NS, Yap YS, Lo SK, et al. Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group’s 5-Dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy—Breast (FACT-B), in Asian breast cancer patients. Qual Life Res. 2013;22:1745–51.CrossRefPubMed Lee CF, Luo N, Ng R, Wong NS, Yap YS, Lo SK, et al. Comparison of the measurement properties between a short and generic instrument, the 5-level EuroQoL Group’s 5-Dimension (EQ-5D-5L) questionnaire, and a longer and disease-specific instrument, the Functional Assessment of Cancer Therapy—Breast (FACT-B), in Asian breast cancer patients. Qual Life Res. 2013;22:1745–51.CrossRefPubMed
11.
Zurück zum Zitat Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C. Observer error in grading performance status in cancer patients. Support Care Cancer. 1999;7:332–5.CrossRefPubMed Taylor AE, Olver IN, Sivanthan T, Chi M, Purnell C. Observer error in grading performance status in cancer patients. Support Care Cancer. 1999;7:332–5.CrossRefPubMed
12.
Zurück zum Zitat Cheung YB, Goh C, Thumboo J, Khoo KS, Wee J. Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires. J Clin Oncol. 2005;23:4936–44.CrossRefPubMed Cheung YB, Goh C, Thumboo J, Khoo KS, Wee J. Variability and sample size requirements of quality-of-life measures: a randomized study of three major questionnaires. J Clin Oncol. 2005;23:4936–44.CrossRefPubMed
13.
Zurück zum Zitat Blagden SP, Charman SC, Sharples LD, Magee LR, Gilligan D. Performance status score: do patients and their oncologists agree? Br J Cancer. 2003;89:1022–7.CrossRefPubMedPubMedCentral Blagden SP, Charman SC, Sharples LD, Magee LR, Gilligan D. Performance status score: do patients and their oncologists agree? Br J Cancer. 2003;89:1022–7.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.CrossRefPubMedPubMedCentral Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res. 2011;20:1727–36.CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Shiroiwa T, Ikeda S, Noto S, Igarashi A, Fukuda T, Saito S, et al. Comparison of value set based on DCE and/or TTO data: scoring for EQ-5D-5L health states in Japan. Value Health. 2016;19:648–54.CrossRefPubMed Shiroiwa T, Ikeda S, Noto S, Igarashi A, Fukuda T, Saito S, et al. Comparison of value set based on DCE and/or TTO data: scoring for EQ-5D-5L health states in Japan. Value Health. 2016;19:648–54.CrossRefPubMed
16.
Zurück zum Zitat Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11:341–53.CrossRefPubMed Tsuchiya A, Ikeda S, Ikegami N, Nishimura S, Sakai I, Fukuda T, et al. Estimating an EQ-5D population value set: the case of Japan. Health Econ. 2002;11:341–53.CrossRefPubMed
17.
Zurück zum Zitat Cella D. FACIT Manual: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. Evanston: CORE; 1997. Cella D. FACIT Manual: Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System. Evanston: CORE; 1997.
18.
Zurück zum Zitat Ng R, Lee CF, Wong NS, Luo N, Yap YS, Lo SK, et al. Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy – Breast (FACT-B) in Asian breast cancer patients. Breast Cancer Res Treat. 2012;131:619–25.CrossRefPubMed Ng R, Lee CF, Wong NS, Luo N, Yap YS, Lo SK, et al. Measurement properties of the English and Chinese versions of the Functional Assessment of Cancer Therapy – Breast (FACT-B) in Asian breast cancer patients. Breast Cancer Res Treat. 2012;131:619–25.CrossRefPubMed
19.
Zurück zum Zitat Dorans NJ. Linking scores from multiple health outcome instruments. Qual Life Res. 2007;16(suppl 1):85–94.CrossRefPubMed Dorans NJ. Linking scores from multiple health outcome instruments. Qual Life Res. 2007;16(suppl 1):85–94.CrossRefPubMed
20.
Zurück zum Zitat Cowling A, Hall P. On pseudodata methods for removing boundary effects in kernel density estimation. J R Stat Soc B. 1996;58:551–63. Cowling A, Hall P. On pseudodata methods for removing boundary effects in kernel density estimation. J R Stat Soc B. 1996;58:551–63.
21.
Zurück zum Zitat Cheung YB, Luo N, Ng R, Lee CF. Mapping the Functional Assessment of Cancer Therapy—Breast (FACT-B) to the 5-level EuroQoL Group’s 5-dimension questionnaire (EQ-5D-5L) utility index in a multi-ethnic Asian population. Health Qual Life Outcomes. 2014;12:180.CrossRefPubMedPubMedCentral Cheung YB, Luo N, Ng R, Lee CF. Mapping the Functional Assessment of Cancer Therapy—Breast (FACT-B) to the 5-level EuroQoL Group’s 5-dimension questionnaire (EQ-5D-5L) utility index in a multi-ethnic Asian population. Health Qual Life Outcomes. 2014;12:180.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods. 1996;1:30–46.CrossRef McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods. 1996;1:30–46.CrossRef
23.
Zurück zum Zitat Wu EQ, Mulani P, Farrell MH, Sleep D. Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormonerefractory prostate cancer patients. Value Health. 2007;10:408–14.CrossRefPubMed Wu EQ, Mulani P, Farrell MH, Sleep D. Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormonerefractory prostate cancer patients. Value Health. 2007;10:408–14.CrossRefPubMed
24.
Zurück zum Zitat Teckle P, McTaggart-Cowan H, Van der Hoek K, Chia S, Melosky B, Gelmon K, et al. Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D. Health Qual Life Outcomes. 2013;11:203.CrossRefPubMedPubMedCentral Teckle P, McTaggart-Cowan H, Van der Hoek K, Chia S, Melosky B, Gelmon K, et al. Mapping the FACT-G cancer-specific quality of life instrument to the EQ-5D and SF-6D. Health Qual Life Outcomes. 2013;11:203.CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Round J, Hawton AJ. Statistical alchemy: conceptual validity and mapping to generate health state utility values. Pharmacoecon Open. 2017;1:233–9.CrossRefPubMedPubMedCentral Round J, Hawton AJ. Statistical alchemy: conceptual validity and mapping to generate health state utility values. Pharmacoecon Open. 2017;1:233–9.CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat McCabe C, Edlin R, Meads D, Brown C, Kharroubi S. Constructing indirect utility models: some observations on the principles and practice of mapping to obtain health state utilities. Pharmacoeconomics. 2013;31:635–41.CrossRefPubMed McCabe C, Edlin R, Meads D, Brown C, Kharroubi S. Constructing indirect utility models: some observations on the principles and practice of mapping to obtain health state utilities. Pharmacoeconomics. 2013;31:635–41.CrossRefPubMed
27.
Zurück zum Zitat Hawton A, Green C, Telford C, Zajicek J, Wright D. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D. Value Health. 2012;15:1084–91.CrossRefPubMed Hawton A, Green C, Telford C, Zajicek J, Wright D. Using the Multiple Sclerosis Impact Scale to estimate health state utility values: mapping from the MSIS-29, version 2, to the EQ-5D and the SF-6D. Value Health. 2012;15:1084–91.CrossRefPubMed
Metadaten
Titel
Development of Conversion Functions Mapping the FACT-B Total Score to the EQ-5D-5L Utility Value by Three Linking Methods and Comparison with the Ordinary Least Square Method
verfasst von
Chun Fan Lee
Raymond Ng
Nan Luo
Yin Bun Cheung
Publikationsdatum
01.10.2018
Verlag
Springer International Publishing
Erschienen in
Applied Health Economics and Health Policy / Ausgabe 5/2018
Print ISSN: 1175-5652
Elektronische ISSN: 1179-1896
DOI
https://doi.org/10.1007/s40258-018-0404-8

Weitere Artikel der Ausgabe 5/2018

Applied Health Economics and Health Policy 5/2018 Zur Ausgabe